B-Cell CLL/lymphoma 11A (Zinc Finger Protein) (BCL11A) (C-Term) Peptide
Quick Overview for B-Cell CLL/lymphoma 11A (Zinc Finger Protein) (BCL11A) (C-Term) Peptide (ABIN2182193)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- GTGSGGSTPH ISGPGPGRPS SKEGRRSDTC SSHTPIRRST QRAQDVWQFS
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-BCL11A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BCL11A (B-Cell CLL/lymphoma 11A (Zinc Finger Protein) (BCL11A))
-
Background
-
The function of this protein remains unknown.
Protein Size: 442 -
Molecular Weight
- 48 kDa
-
UniProt
- B4DT16
Target
-